These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12738725)

  • 1. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
    Dong Y; Kaushal A; Brattsand M; Nicklin J; Clements JA
    Clin Cancer Res; 2003 May; 9(5):1710-20. PubMed ID: 12738725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
    Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
    J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.
    Planque C; de Monte M; Guyetant S; Rollin J; Desmazes C; Panel V; Lemarié E; Courty Y
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1260-6. PubMed ID: 15766562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
    Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
    Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
    Diamandis EP; Borgoño CA; Scorilas A; Yousef GM; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M
    Tumour Biol; 2003; 24(6):299-309. PubMed ID: 15004490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
    Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
    Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.
    Komatsu N; Takata M; Otsuki N; Toyama T; Ohka R; Takehara K; Saijoh K
    J Invest Dermatol; 2003 Sep; 121(3):542-9. PubMed ID: 12925213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the serine protease kallikrein 7 and its inhibitor antileukoprotease is decreased in prostate cancer.
    Xuan Q; Yang X; Mo L; Huang F; Pang Y; Qin M; Chen Z; He M; Wang Q; Mo ZN
    Arch Pathol Lab Med; 2008 Nov; 132(11):1796-801. PubMed ID: 18976018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.
    Li X; Liu J; Wang Y; Zhang L; Ning L; Feng Y
    Cancer Sci; 2009 Apr; 100(4):601-7. PubMed ID: 19453546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
    Yousef GM; White NM; Kurlender L; Michael I; Memari N; Robb JD; Katsaros D; Stephan C; Jung K; Diamandis EP
    Tumour Biol; 2004; 25(5-6):221-7. PubMed ID: 15627884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
    Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
    Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
    Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
    Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
    Kuo KT; Mao TL; Jones S; Veras E; Ayhan A; Wang TL; Glas R; Slamon D; Velculescu VE; Kuman RJ; Shih IeM
    Am J Pathol; 2009 May; 174(5):1597-601. PubMed ID: 19349352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7.
    Caubet C; Jonca N; Brattsand M; Guerrin M; Bernard D; Schmidt R; Egelrud T; Simon M; Serre G
    J Invest Dermatol; 2004 May; 122(5):1235-44. PubMed ID: 15140227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors.
    Shigemasa K; Tanimoto H; Underwood LJ; Parmley TH; Arihiro K; Ohama K; O'Brien TJ
    Int J Gynecol Cancer; 2001; 11(6):454-61. PubMed ID: 11906548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.